SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2371)4/14/2005 2:34:28 PM
From: bob zagorin  Respond to of 3044
 
there was an analyst on cnbc (sorry i missed them name as the tv was on in background) who just recommended mlnm this morning going into the asco meetings and citing velcade. his thesis was that bio stock usually run into that meeting and then selloff but they are late this year.....



To: tuck who wrote (2371)4/14/2005 2:43:24 PM
From: nigel bates  Respond to of 3044
 
Cool.

Current PII in MM is monotherapy.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News